세계의 트라마돌(Tramadol) 의약품 시장 보고서(2025년)

Tramadol is a prescription opioid medication designed to alleviate moderate to moderately severe pain by altering how the brain and nervous system interpret pain signals. It achieves this effect by binding to opioid receptors and inhibiting the reuptake of serotonin and norepinephrine, thereby amplifying its analgesic properties.

Tramadol is available in various forms, including tablets, capsules, liquids, suspensions, and others. Tramadol tablets are solid-dose forms taken orally and meant to be swallowed whole. The medication is commonly prescribed for therapeutic applications such as pain relief, treatment of anxiety disorders, and postoperative pain management. It can be administered via oral, intravenous, or intramuscular routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with end users spanning clinics, hospitals, and other healthcare settings.

The tramadol drug market research report is one of a series of new reports from The Business Research Company that provides tramadol drug market statistics, including tramadol drug industry global market size, regional shares, competitors with a tramadol drug market share, detailed tramadol drug market segments, market trends and opportunities, and any further data you may need to thrive in the tramadol drug industry. The tramadol drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tramadol drug market size has grown strongly in recent years. It will grow from $4.38 billion in 2024 to $4.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. This growth during the historical period was supported by factors such as the growing burden of chronic pain, an aging population, increased utilization of opioid-based analgesics, greater public awareness of pain treatment options, and enhanced accessibility to prescription drugs.

The tramadol drug market size is expected to see strong growth in the next few years. It will grow to $6.30 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. Drivers for this forecast period include expanded insurance coverage for pain management therapies, a surge in postoperative interventions, a higher prevalence of orthopedic ailments, a boom in online pharmacy adoption, and greater penetration in developing regions. Key trends expected include innovations in drug delivery technologies, introduction of abuse-deterrent drug formats, use of combination treatments with non-opioid agents, AI-powered drug development, and the implementation of smart packaging for enhanced medication monitoring.

The increasing prevalence of orthopedic disorders is anticipated to drive the growth of the tramadol drug market. Orthopedic disorders refer to medical conditions that impact the bones, joints, muscles, ligaments, or tendons, often resulting in pain and restricted movement. As the aging population continues to grow, the occurrence of age-related conditions such as osteoarthritis and osteoporosis is rising, contributing to joint degeneration and bone weakening. Tramadol proves beneficial for managing orthopedic disorders by alleviating moderate to severe pain associated with fractures, arthritis, or post-surgical recovery. It works by acting on the central nervous system to diminish the perception of pain. For example, in March 2023, a report by the Office for Health Improvement & Disparities, a UK-based government department, revealed that in 2022, 17.6% of individuals aged 16 and above reported having a long-term musculoskeletal (MSK) condition, an increase from 17.0% in 2021. Thus, the rising incidence of orthopedic disorders is contributing to the growth of the tramadol drug market.

The increasing healthcare expenditure is also expected to support the expansion of the tramadol drug market. Healthcare expenditure encompasses the total funds allocated for medical services, treatments, and health-related resources over a specific period. As the population ages, there is a rising demand for healthcare services, long-term care, and age-related treatments, which together exert a heavier financial load on healthcare systems. This growing expenditure underpins the availability and distribution of tramadol by supporting the infrastructure required for its research, regulation, and usage. For instance, in April 2025, the American Medical Association, a U.S.-based professional association, reported that in 2023, health spending in the U.S. increased by 7.5%, totaling $4.9 trillion or $14,570 per person, a notable rise compared to the 4.6% growth in 2022. Therefore, the rising healthcare expenditure is contributing to the expansion of the tramadol drug market.

Leading companies in the tramadol drug market are prioritizing regulatory approvals to broaden their product offerings and enter new regional markets. Regulatory approvals are the formal authorizations issued by governmental health agencies, permitting pharmaceutical firms to legally market and distribute drugs within specific regions. For instance, in July 2022, Kowa Pharmaceuticals America Inc., a U.S.-based pharmaceutical company, announced the publication of Phase 3 clinical trial results for SEGLENTIS, a co-crystal formulation combining celecoxib 56 mg and tramadol hydrochloride 44 mg. Approved by the U.S. Food and Drug Administration, SEGLENTIS is indicated for treating moderate-to-severe acute pain in appropriate adult patients. This multimodal analgesic operates through four complementary mechanisms of pain relief, engaging both peripheral and central pathways, making it a novel alternative for managing acute pain in adults when other treatments prove insufficient.

Major players in the tramadol drug market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Limited, Grunenthal GmbH, Nippon Shinyaku Co., Ltd., Ipca Laboratories Ltd., Piramal Pharma Solutions Limited, MSN Laboratories Pvt. Ltd., Ajanta Pharma Limited, Wockhardt Ltd., Troikaa Pharmaceuticals Ltd., Sakar Healthcare Limited, Unosource Pharma Limited, Labopharm Inc., Hiral Laboratories Limited, Nuray Chemicals Pvt. Ltd., Lavybens Pharma Private Limited, Jubilant Generics Limited, SLR Pharma Pvt. Ltd.

North America was the largest region in the tramadol drug market in 2024. The regions covered in tramadol drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tramadol drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tramadol drug market consists of sales of orally disintegrating tablets, oral suspensions, suppositories, topical gels and combination products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tramadol Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tramadol drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tramadol drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tramadol drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Tablet; Capsule; Liquid; Suspension; Other Types
• 2) By Therapeutic Use: Pain Management; Anxiety Disorder; Postoperative Pain
• 3) By Route Of Administration: Oral; Intravenous; Intramuscular
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By Application: Clinic; Hospital; Other Applications
• Subsegments:
• 1) By Tablet: Immediate-Release Tablets; Extended-Release Tablets; Orally Disintegrating Tablets; Effervescent Tablets
• 2) By Capsule: Hard Gelatin Capsules; Soft Gelatin Capsules; Modified-Release Capsules
• 3) By Liquid: Oral Solution; Injectable Solution; Intravenous (IV) Formulation
• 4) By Suspension: Reconstitutable Powder Suspension; Ready-To-Use Oral Suspension
• 5) By Other Types: Suppositories; Transdermal Patches; Sublingual Tablets; Buccal Films; Topical Creams Or Gels
• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Aurobindo Pharma Limited; Grunenthal GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tramadol Drug Market Characteristics

3. Tramadol Drug Market Trends And Strategies

4. Tramadol Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tramadol Drug Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tramadol Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tramadol Drug Market Growth Rate Analysis
• 5.4. Global Tramadol Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tramadol Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tramadol Drug Total Addressable Market (TAM)

6. Tramadol Drug Market Segmentation

• 6.1. Global Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Capsule
• Liquid
• Suspension
• Other Types
• 6.2. Global Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Anxiety Disorder
• Postoperative Pain
• 6.3. Global Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• 6.4. Global Tramadol Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Tramadol Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other Applications
• 6.6. Global Tramadol Drug Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• Orally Disintegrating Tablets
• Effervescent Tablets
• 6.7. Global Tramadol Drug Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gelatin Capsules
• Modified-Release Capsules
• 6.8. Global Tramadol Drug Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Solution
• Injectable Solution
• Intravenous (IV) Formulation
• 6.9. Global Tramadol Drug Market, Sub-Segmentation Of Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reconstitutable Powder Suspension
• Ready-To-Use Oral Suspension
• 6.10. Global Tramadol Drug Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Suppositories
• Transdermal Patches
• Sublingual Tablets
• Buccal Films
• Topical Creams Or Gels

7. Tramadol Drug Market Regional And Country Analysis

• 7.1. Global Tramadol Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tramadol Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tramadol Drug Market

• 8.1. Asia-Pacific Tramadol Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tramadol Drug Market

• 9.1. China Tramadol Drug Market Overview
• 9.2. China Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tramadol Drug Market

• 10.1. India Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tramadol Drug Market

• 11.1. Japan Tramadol Drug Market Overview
• 11.2. Japan Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tramadol Drug Market

• 12.1. Australia Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tramadol Drug Market

• 13.1. Indonesia Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tramadol Drug Market

• 14.1. South Korea Tramadol Drug Market Overview
• 14.2. South Korea Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tramadol Drug Market

• 15.1. Western Europe Tramadol Drug Market Overview
• 15.2. Western Europe Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tramadol Drug Market

• 16.1. UK Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tramadol Drug Market

• 17.1. Germany Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tramadol Drug Market

• 18.1. France Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tramadol Drug Market

• 19.1. Italy Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tramadol Drug Market

• 20.1. Spain Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tramadol Drug Market

• 21.1. Eastern Europe Tramadol Drug Market Overview
• 21.2. Eastern Europe Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tramadol Drug Market

• 22.1. Russia Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tramadol Drug Market

• 23.1. North America Tramadol Drug Market Overview
• 23.2. North America Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tramadol Drug Market

• 24.1. USA Tramadol Drug Market Overview
• 24.2. USA Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tramadol Drug Market

• 25.1. Canada Tramadol Drug Market Overview
• 25.2. Canada Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tramadol Drug Market

• 26.1. South America Tramadol Drug Market Overview
• 26.2. South America Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tramadol Drug Market

• 27.1. Brazil Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tramadol Drug Market

• 28.1. Middle East Tramadol Drug Market Overview
• 28.2. Middle East Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tramadol Drug Market

• 29.1. Africa Tramadol Drug Market Overview
• 29.2. Africa Tramadol Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tramadol Drug Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tramadol Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tramadol Drug Market Competitive Landscape And Company Profiles

• 30.1. Tramadol Drug Market Competitive Landscape
• 30.2. Tramadol Drug Market Company Profiles
  • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Grunenthal GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Tramadol Drug Market Other Major And Innovative Companies

• 31.1. Nippon Shinyaku Co., Ltd.
• 31.2. Ipca Laboratories Ltd.
• 31.3. Piramal Pharma Solutions Limited
• 31.4. MSN Laboratories Pvt. Ltd.
• 31.5. Ajanta Pharma Limited
• 31.6. Wockhardt Ltd.
• 31.7. Troikaa Pharmaceuticals Ltd.
• 31.8. Sakar Healthcare Limited
• 31.9. Unosource Pharma Limited
• 31.10. Labopharm Inc.
• 31.11. Hiral Laboratories Limited
• 31.12. Nuray Chemicals Pvt. Ltd.
• 31.13. Lavybens Pharma Private Limited
• 31.14. Jubilant Generics Limited
• 31.15. SLR Pharma Pvt. Ltd.

32. Global Tramadol Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tramadol Drug Market

34. Recent Developments In The Tramadol Drug Market

35. Tramadol Drug Market High Potential Countries, Segments and Strategies

• 35.1 Tramadol Drug Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tramadol Drug Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tramadol Drug Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer